GOLDMAN SACHS GROUP INC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 46 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$400,943
+23.2%
153,618
+69.0%
0.00%
Q2 2023$325,476
+47.9%
90,915
-9.9%
0.00%
Q1 2023$220,080
+10.8%
100,954
+511.6%
0.00%
Q4 2022$198,579
-44.1%
16,507
-69.9%
0.00%
Q3 2022$355,000
+173.1%
54,902
+93.6%
0.00%
Q2 2022$130,000
-78.6%
28,363
-59.6%
0.00%
Q1 2022$607,000
-63.7%
70,183
-40.0%
0.00%
Q4 2021$1,672,000
+284.4%
117,034
+492.0%
0.00%
Q3 2021$435,000
-7.2%
19,768
-43.6%
0.00%
Q2 2021$469,000
+133.3%
35,055
+77.4%
0.00%
Q1 2021$201,00019,7550.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders